CCTN - MALE CONTRACEPTIVE - DMAU 28 DAY STUDY

University Of Washington, Seattle WA

Investigators

Abstract

Phase I Male Contraceptive Trial, Dimethylandrolone undecanoatehase (DMAU), shown in animal studies to inhibit spermatogenesis. Test single dose in man as clinical trial for contraception.